Shanghai Medicilon Inc. (SHA:688202)
China flag China · Delayed Price · Currency is CNY
74.22
-5.88 (-7.34%)
Nov 16, 2026, 4:00 PM EST

Shanghai Medicilon Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-46.14-167.83-330.85-33.21338.24282.22
Depreciation & Amortization
108.88108.88111.31103.6679.2258.5
Other Amortization
32.7232.7253.7638.6225.6518.04
Loss (Gain) From Sale of Assets
1.951.951.120.340.871.04
Asset Writedown & Restructuring Costs
5.135.1318.42-1.640.84
Loss (Gain) From Sale of Investments
-15.17-15.17-7.02-6.33-2.46-
Provision & Write-off of Bad Debts
66.2366.23110.4544.0721.867.68
Other Operating Activities
9.3619.8130.1827.26-3.655.89
Change in Accounts Receivable
25.1325.13-17.22-60.36-434.33-104.96
Change in Inventory
-15.64-15.6445.21-11.69-87.64-50.79
Change in Accounts Payable
82.7782.7710.05-45.198.11203.04
Change in Other Net Operating Assets
-21.64-21.641.962.7615.5919.28
Operating Cash Flow
216.41105.17-22.7533.32-21.33452.94
Operating Cash Flow Growth
144.59%----118.00%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-173-69.03-110.39-185.68-404.06-292.71
Sale of Property, Plant & Equipment
0.120.070.010.27-0.16
Cash Acquisitions
------7
Investment in Securities
14.19132.7723.27-604.6590-100
Other Investing Activities
9.3310.75-2.862.522.44-
Investing Cash Flow
-149.3674.56-89.97-787.55-311.62-399.55

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
----279-
Long-Term Debt Issued
-360.08320457.1--
Total Debt Issued
116.72360.08320457.1279-
Short-Term Debt Repaid
-----50-
Long-Term Debt Repaid
--512.48-379.48-357.74-20.19-13.9
Lease Payments
-18.98-18.98-23.39-20.72-20.19-13.9
Total Debt Repaid
-317.26-512.48-379.48-357.74-70.19-13.9
Net Debt Issued (Repaid)
-200.53-152.4-59.4899.37208.81-13.9
Issuance of Common Stock
1.8723.94-1,0076.516.99
Repurchase of Common Stock
-50.09-50.09-40-19.99--
Common Dividends Paid
-4.33-7.42-6.97-42.14-87.33-39.06
Other Financing Activities
51.36--0.26-14.45-19.06-60
Financing Cash Flow
-201.73-185.97-106.711,030108.94-105.97

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-9.96-2.116.13-0.198.17-0.99
Net Cash Flow
-144.64-8.34-213.3275.34-215.84-53.58

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
43.4136.14-133.14-152.36-425.39160.22
Free Cash Flow Growth
115.00%----79.93%
Free Cash Flow Margin
2.83%3.11%-12.83%-11.16%-25.64%13.73%
Free Cash Flow Per Share
0.330.27-0.99-1.19-3.501.32
Levered Free Cash Flow
63.42160.81-78.05-159.98-583.3614.51
Unlevered Free Cash Flow
67.54166.76-72.83-153.94-580.315.77
Free Cash Flow After Leases
24.4317.16-156.53-173.08-445.58146.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
--9.39-30.13-55.2128.71-8.88
Change in Working Capital
53.4553.45-10.12-141.09-482.7278.72